COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 87 filers reported holding COGENT BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,889,918 | -17.7% | 501,530 | 0.0% | 6.28% | +23.1% |
| Q2 2023 | $5,938,115 | +9.7% | 501,530 | 0.0% | 5.10% | +14.0% |
| Q1 2023 | $5,411,509 | -6.7% | 501,530 | 0.0% | 4.47% | +6.6% |
| Q4 2022 | $5,797,687 | -22.5% | 501,530 | 0.0% | 4.20% | -5.5% |
| Q3 2022 | $7,483,000 | +65.4% | 501,530 | 0.0% | 4.44% | +51.5% |
| Q2 2022 | $4,524,000 | +20.4% | 501,530 | 0.0% | 2.93% | +58.3% |
| Q1 2022 | $3,756,000 | -12.7% | 501,530 | 0.0% | 1.85% | +18.7% |
| Q4 2021 | $4,303,000 | +2.0% | 501,530 | 0.0% | 1.56% | +28.1% |
| Q3 2021 | $4,218,000 | +58.7% | 501,530 | 0.0% | 1.22% | +78.4% |
| Q2 2021 | $2,658,000 | -39.6% | 501,530 | 0.0% | 0.68% | -33.5% |
| Q1 2021 | $4,403,000 | -19.9% | 501,530 | +2.5% | 1.02% | -19.3% |
| Q4 2020 | $5,496,000 | – | 489,380 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $17,507,000 | 6.26% |
| COMMODORE CAPITAL LP | 760,025 | $8,535,000 | 4.64% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $18,222,000 | 3.12% |
| Ghost Tree Capital, LLC | 1,100,000 | $12,353,000 | 2.75% |
| Logos Global Management LP | 1,920,500 | $21,567,000 | 1.85% |
| Altium Capital Management LP | 432,563 | $4,858,000 | 1.81% |
| VR Adviser, LLC | 1,088,817 | $12,227,000 | 1.80% |
| Atlas Venture Associates IX, LLC | 916,196 | $10,289,000 | 1.63% |
| Atlas Venture Associates XI, LLC | 916,196 | $10,289,000 | 1.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 235,066 | $2,640,000 | 1.53% |